Pharma Journalist -

ImmunoGen Inc. a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced a global, multi-year definitive licensing agreement…
Read More...

Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, announced the closing of a $236 million Series D…
Read More...

Adcentrx Therapeutics a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate therapeutic development, and AvantGen, a leader in the use of yeast…
Read More...

Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development announced that it has executed a non-binding term sheet with Avicanna Inc. ("Avicanna") to assess…
Read More...

Novavax, Inc. announced that the Singapore Health Sciences Authority (HSA) has issued interim authorization for Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) for active…
Read More...

Collegium Pharmaceutical, Inc. and BioDelivery Sciences International, Inc. announced a definitive agreement pursuant to which Collegium will acquire BDSI for $5.60 per share in cash.…
Read More...

Axcella Therapeutics, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions,…
Read More...

 Pfizer Inc. and BioNTech SE announced plans to extend their rolling submission to the U.S. Food and Drug Administration (FDA) seeking to amend the Emergency Use Authorization of the…
Read More...

RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines. Beyond mRNA vaccines, innovative developments are being made using siRNA, microRNA, tRNA and…
Read More...

Quoin Pharmaceuticals Ltd. announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has entered into an exclusive Distribution Agreement with ER-Kim, a partner for…
Read More...